Treatment Strategies to Limit Hypoglycemia
Studies summarized in this slide show focus on fine-tuning insulin-containing regimens to enhance glucose control and avoid variability.
ADA 2017: Hypoglycemia and the Role of Glycemic Variability
Glycemic variability fuels hypoglycemia but in one study from ADA 2017 is found to actually help predict hypoglycemic events.
ADA 2017: Evaluating Cardiovascular Safety of Antidiabetic Agents
Cardiovascular risk/benefit profiles of pioglitazone and the SGLT2 inhibitor class are summarized, based on reports at ADA 2017.
ADA 2017: CV Complications of Diabetes
A1C vs FPG to diagnose prediabetes; prediabetes and CHF; and how much weight loss is too much? Reports from ADA 2017.
ADA 2017: Insulins go Head-to-Head
Insulin degludec vs glargine--which costs less per anum and why? We summarize this study and 2 other direct insulin comparisons reported at ADA 2017.
ADA 2017: Oral Agents Under Review
When to start screening for B12 deficiency in your diabetes patients taking metformin? We review a dose-response diet study plus 2 others on oral drugs.
T2DM: Intensifying Rx When Diet, Lifestyle and OADs Aren't Enough
A how-to overview of how to advance therapy for hyperglycemia and ASCVD risk factors in patients with T2DM.
Self-monitoring Blood Glucose in T2DM: It's Essential
Self-monitoring of blood glucose is critical for all patients with T2DM and their physicians.The numbers help modify behavior and Rx.
7 Top Diabetes Apps for Primary Care
Seven top diabetes apps for PCPs include insulin calculators, Rx algorithms, comorbidity support, and patient tracking tools.
Prescribers Counseled on Defensible Pain Treatment Practice
"Ladies and gentlemen of the jury," began the PAINWeek 2016 speaker, in mock trial defense of a physician for over-prescribing opioid meds.
Panelists Guide Around Pitfalls in CDC Opioid Guideline
A PAINWeek 2016 expert panel gave attendees behind-the-scenes insight into the process behind the CDC's final recommendations.
Are Abuse-deterrent Opioids Working?
Four studies presented at PAINWeek 2016 review the success of abuse-deterrent opioid formulations in stemming abuse and non-medical use.
Abuse-Deterrent Opioids Broken Down at Pain Conference
At PAINWeek 2016, a session on abuse-deterrent formulations underscored that this drug class will never be free from abuse potential.
Behavioral Management of Migraine: PAINWeek 2016
A PAINWeek audience experienced behavioral Rx during a presentation on effective non-drug treatment for migraine.
Prevent Chronic Pain with Transformative Care
This PAINWeek 2016 presentation focused on how to more deeply involve patients in their own pain management plan.
Multidisciplinary Asthma Care: It Takes a Village
Effective asthma care requires attention to comorbidities, complications, and human characteristics of each patient. Speakers at CHEST 2015 described "the village."
Clinical Evolution in Asthma and COPD
New approaches discussed at CHEST 2015 ranged from the impact of bariatric surgery on asthma control to endobronchial valve placement in COPD.
Emerging Pharmacotherapy in COPD: Update from CHEST 2015
In a well-attended session at CHEST 2015 a number of promising new therapies for treating COPD were reviewed by study authors.
Safety of COPD Medications: Current Evidence
COPD is one of the primary lung diseases seen in primary care. A CHEST 2015 panel session reinforced that treatment is often a risk/benefit balance.
Consistent Asthma Control: One Patient at a Time
The best asthma care is not good enough if the patient is nonadherent. Applied "humanomics" as an approach to chronic care was discussed this week at CHEST 2015.
